- Corporate Officers - C
- Chin Mark
Insider Trading History of Chin Mark
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chin Mark since 2018.
This trader's CIK number is 1734389.
At the time of last reporting, Chin Mark was the Director of Iterum Therapeutics Plc. (stock ticker symbol ITRM).
Also see all insider trading activities at Iterum Therapeutics Plc.
Note that in the past
Chin Mark also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Iterum Therapeutics Plc (ITRM) by Chin Mark
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ITRM | 0 | $0 | 0 | $0 | 15,853 | $0 |
| 2022 | ITRM | 0 | $0 | 0 | $0 | 36,798 | $0 |
| 2020 | ITRM | 0 | $0 | 0 | $0 | 5,703 | $0 |
| 2019 | ITRM | 0 | $0 | 0 | $0 | 6,154 | $0 |
| 2018 | ITRM | 395,606 | $4,742,678 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Enliven Therapeutics, Inc. (IMRA) by Chin Mark
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | IMRA | 1,333,333 | $7,999,998 | 0 | $0 | 0 | $0 |
| 2020 | IMRA | 187,500 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pyxis Oncology, Inc. (PYXS) by Chin Mark
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | PYXS | 0 | $0 | 1,745,761 | $5,324,571 | 0 | $0 |
| 2021 | PYXS | 312,500 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Harpoon Therapeutics, Inc. (HARP) by Chin Mark
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | HARP | 0 | $0 | 319,760 | $5,652,241 | 0 | $0 |
Insider trading activities at 4 companies by Chin Mark:
1. Iterum Therapeutics Plc (ITRM)
2. Enliven Therapeutics, Inc. (IMRA)
3. Pyxis Oncology, Inc. (PYXS)
4. Harpoon Therapeutics, Inc. (HARP)
Table 1. Insider trading of Iterum Therapeutics Plc (ITRM) by Chin Mark
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-15 | ITRM | Option Ex | 15,853 | .00 | 0 |
| 2022-06-23 | ITRM | Option Ex | 36,798 | .00 | 0 |
| 2020-07-01 | ITRM | Option Ex | 5,703 | .00 | 0 |
| 2019-05-24 | ITRM | Option Ex | 6,154 | .00 | 0 |
| 2018-10-30 | ITRM | Buy | 58,000 | 6.10 | 353,800 |
| 2018-05-30 | ITRM | Buy | 337,606 | 13.00 | 4,388,878 |
Table 2. Insider trading of Enliven Therapeutics, Inc. (IMRA) by Chin Mark
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-07-16 | IMRA | Buy | 1,333,333 | 6.00 | 7,999,998 |
| 2020-03-16 | IMRA | Buy | 187,500 | 16.00 | 3,000,000 |
Table 3. Insider trading of Pyxis Oncology, Inc. (PYXS) by Chin Mark
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-04-21 | PYXS | Sale | 1,745,761 | 3.05 | 5,324,571 |
| 2021-10-13 | PYXS | Buy | 312,500 | 16.00 | 5,000,000 |
Table 4. Insider trading of Harpoon Therapeutics, Inc. (HARP) by Chin Mark
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-12-13 | HARP | Sale | 11,002 | 17.21 | 189,344 |
| 2019-12-16 | HARP | Sale | 13,080 | 17.02 | 222,686 |
| 2019-12-17 | HARP | Sale | 12,476 | 16.83 | 209,971 |
| 2019-12-09 | HARP | Sale | 103,754 | 18.21 | 1,889,049 |
| 2019-12-10 | HARP | Sale | 131,696 | 16.91 | 2,226,979 |
| 2019-12-06 | HARP | Sale | 47,752 | 19.14 | 914,212 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Chin Mark
(Director of Iterum Therapeutics Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.